1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Industrial Microbiology Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing production of antibiotics, drug products, and natural cosmetic ingredients
5.1.1.2. Rising concerns about waste management and government initiatives for renewable energy
5.1.1.3. Increasing consumer preference for novel and nutritionally rich food and beverage options
5.1.2. Restraints
5.1.2.1. Chances of contamination and the need for precise control of environmental parameters
5.1.3. Opportunities
5.1.3.1. Advancements and research initiatives to optimize industrial microbiology processes
5.1.3.2. Inclination towards adoption of precision agriculture for efficient crop production
5.1.4. Challenges
5.1.4.1. Limitations of machinery and process handling of industrial microbiology and lack of skilled personnel
5.2. Market Segmentation Analysis
5.2.1. Product: Development of advanced equipment for streamlining industrial microbiology processes
5.2.2. Test Type: Utilization of microbial limits testing to ensure sterility of pharmaceutical and medical products
5.2.3. Application: Growing sustainability and waste management concerns driving the utilization of industrial microbiology in the environmental industry
5.3. Market Trend Analysis
5.3.1. Technological advances in industrial microbiology solutions in the Americas region backed by strong presence of key players and increasing demand from developed industrial landscape
5.3.2. Potential for expansion and technology integration in the industrial microbiology sector of emerging countries in APAC, driven by the rise of sustainable practices, and availability of expertise
5.3.3. Strong R&D background of EMEA region in industrial microbiology backed by the presence of established companies and robust government initiatives to accelerate microbe usage across industries
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Industrial Microbiology Market, by Product Type
6.1. Introduction
6.2. Consumables
6.3.1. Media
6.3.2. Reagents & Strains
6.3. Equipment & Systems
6.4.1. Air Monitoring Systems
6.4.2. Automated Equipment
6.4.3. Filtration Pumps & Systems
6.4.4. Incubators & Culture Apparatus
6.4.5. Microbial Detection Systems
6.4. Laboratory Supplies
6.5.1. Bags & Bottles
6.5.2. Filtration Disc & Membranes
6.5.3. Loop & Needles
6.5.4. Petri Dishes, Racks, Seals, Plates & Holders
7. Industrial Microbiology Market, by Test Type
7.1. Introduction
7.2. Bio-Burden Testing
7.3. Microbial Limits Testing
7.4. Sterility Testing
7.5. Water & Environmental Testing
8. Industrial Microbiology Market, by Application
8.1. Introduction
8.2. Agricultural
8.3. Cosmetic or Personal Care
8.4. Environmental
8.5. Food & Beverage
8.6. Pharmaceutical & Biotechnology
8.7. Wastewater & Sewage Treatment
9. Americas Industrial Microbiology Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Industrial Microbiology Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Industrial Microbiology Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
12.3.1. Merger & Acquisition
12.3.1.1. New Acquisition to Accelerate Microbiome Therapeutics Manufacture
12.3.1.2. Sartorius Stedim Biotech to Acquire Polyplus
12.3.2. Agreement, Collaboration, & Partnership
12.3.2.1. Visolis and Ginkgo Bioworks Announce Partnership to Improve Microbial Strain for Bio-Isoprene and Sustainable Aviation Fuel Production
12.3.2.2. InDevR Partners with bioMérieux
12.3.3. New Product Launch & Enhancement
12.3.3.1. QIAGEN Launches Complete Sample to Insight Workflow for Microbiome Research
12.3.3.2. Eppendorf Introduces the First Microcentrifuge with Hydrocarbon Cooling
12.3.3.3. Charles River Laboratories Launches Next Generation Sequencing Services for Bacterial Identification and Fungal ID
12.3.3.4. BD Launches Third-GenerationTotal Lab Automation System
12.3.4. Investment & Funding
12.3.4.1. bNovate Technologies Raises USD 13.4 Million(~CHF 12 million)
12.3.4.2. 3M Invests USD 146M in Biopharma Filtration Technology
12.3.5. Award, Recognition, & Expansion
12.3.5.1. Solvay Announces Plans to Build a Multipurpose Microbiology Lab in Europe
12.3.5.2. Sysmex to Establish New Manufacturing Base in India – Creating a manufacturing structure in India to Support Sustainable Growth
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. 3M Company
13.1.2. Agilent Technologies, Inc.
13.1.3. Asiagel Corporation
13.1.4. Becton, Dickinson and Company
13.1.5. Bio-Rad Laboratories, Inc.
13.1.6. BioMerieux SA
13.1.7. bNovate Technologies SA
13.1.8. Bruker Corporation
13.1.9. Charles River Laboratories International, Inc.
13.1.10. Condalab
13.1.11. Corning Incorporated
13.1.12. Cysal GmbH
13.1.13. Danaher Corporation
13.1.14. ELITechGroup Inc.
13.1.15. Eppendorf SE
13.1.16. Fujifilm Holdings Corporation
13.1.17. HiMedia Laboratories Private Limited
13.1.18. HyLabs Ltd.
13.1.19. Merck KGaA
13.1.20. Microbe Investigations AG
13.1.21. Novamed, Ltd. by Simplivia Healthcare Ltd.
13.1.22. Qiagen N. V.
13.1.23. Reshape ApS
13.1.24. Sartorius AG
13.1.25. Solenis LLC
13.1.26. Sporian Microsystems Inc.
13.1.27. SSI Diagnostica A/S
13.1.28. Sysmex Corporation
13.1.29. Thermo Fisher Scientific Inc.
13.1.30. Vermicon AG
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
